Sanofi
SNY
SNY
751 hedge funds and large institutions have $10.8B invested in Sanofi in 2025 Q4 according to their latest regulatory filings, with 119 funds opening new positions, 249 increasing their positions, 260 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
4% less capital invested
Capital invested by funds: $11.2B → $10.8B (-$413M)
4% less repeat investments, than reductions
Existing positions increased: 249 | Existing positions reduced: 260
38% less call options, than puts
Call options by funds: $99.3M | Put options by funds: $160M
Holders
751
Holding in Top 10
7
Calls
$99.3M
Puts
$160M
Top Buyers
| 1 | +$81.8M | |
| 2 | +$76.4M | |
| 3 | +$57.9M | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$50.7M |
| 5 |
MIP
Mondrian Investment Partners
London,
United Kingdom
|
+$42.5M |
Top Sellers
| 1 | -$617M | |
| 2 | -$149M | |
| 3 | -$76.3M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$65.9M |
| 5 |
Millennium Management
New York
|
-$64.3M |
